RESCUE CHEMIOTERAPY WITH MI Mitomicina e Isofosfamide in pancreatic adenocarcinoma with metastasis a phase II study. - ND

Phase 1

• Conditions: patients with pancreatic adenocarcinoma in progression after previous chemioterapic therapy with Gemcitabina; MedDRA version: 6.1Level: PTClassification code 10052747

• Registration Number: EUCTR2006-001163-29-IT
• Lead Sponsor: OSPEDALE S. RAFFAELE

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2006-03-14
• Last Update Posted: 26 October 2021

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: 34

Inclusion Criteria

pancreatic carcinoma diagnosis with metastasis, previous chemioterpy, age 50 and 76
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

cerebral metastasis, pregnancy, previous chemiotherapy with ifosfamide or mytomicin

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified